SCHEMBL6160184

SCHEMBL6160184

CC(=O)NC1(c2ccccc2)CCN(C(=O)C(F)(F)F)CC1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
POLB P06746 1/20 0.59
KDM4E B2RXH2 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
HTT P42858 2/20 0.47
CYP2C19 P33261 2/20 0.47
GAA P10253 2/20 0.46
CNR1 P21554 1/20 0.46
CNR2 P34972 1/20 0.46
TACR3 P29371 3/20 0.42
HDAC3 O15379 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
TACR1 P25103 2/20 0.41
KDM1A O60341 1/20 0.41
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13774961 0.84 ALDH1A1 (0.71) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL8365979 0.82 ALDH1A1 (0.67) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL14000285 0.80 POLB (0.68) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL7600715 0.79 ALDH1A1 (0.60) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL14485601 0.79 POLB (0.63) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL5987740 0.79 POLB (0.65) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL27099785 0.79 MGLL (0.43) HSD17B10KDM1A
SCHEMBL6159060 0.77 ALDH1A1 (0.50) ALDH1A1POLBDRD2
SCHEMBL14671980 0.76 POLB (0.63) ALDH1A1POLBKDM4EHPGDHSD17B10
SCHEMBL2932067 0.76 ALDH1A1 (0.51) ALDH1A1POLBKDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0739891-B1 Substituted heterocycles ASTRAZENECA AB (SE) 2005-01-19 EP disclosed
EP-0680962-B1 Heterocyclic compounds ASTRAZENECA AB (SE) 2003-08-20 EP disclosed
US-6355695-B1 ANTIHISTAMINES; ASTHMA THERAPY ZENECA LIMITED (SE) 2002-03-12 US disclosed
US-6235757-B1 ANTIHISTAMINES ZENECA LIMITED (GB) 2001-05-22 US disclosed
US-6051580-A Substituted heterocycles ZENECA LIMITED 2000-04-18 US disclosed
US-5889024-A Substituted heterocycles ZENECA LIMITED (GB) 1999-03-30 US disclosed
US-5739149-A TREATING ASTHMA ZENECA LIMITED (GB) 1998-04-14 US disclosed
US-5635509-A ASTHMA; BRONCHODILATOR AGENTS; VASODILATION MICROVASCULAR PERMEABILITY; MAST CELLS ZENECA LIMITED (GB) 1997-06-03 US disclosed
EP-0739891-A2 Substituted heterocycles ZENECA LIMITED (GB) 1996-10-30 EP disclosed
EP-0680962-A2 Heterocyclic compounds ZENECA LIMITED (GB) 1995-11-08 EP disclosed